Results 201 to 210 of about 61,117 (342)

Mineralocorticoid receptor antagonists in heart failure: a systematic review and meta-analysis. [PDF]

Front Cardiovasc Med
Zhang Y, Bao YC, Wang LX, Zhao HJ, Sun J, Sun L, Duan W, Du M, Wang LJ, An QY, Yang WZ.   +10 more
europepmc   +1 more source

Effectiveness and safety of combining thiazides with loop diuretics vs. loop diuretics monotherapy in patients with acute decompensated heart failure: A retrospective cohort study

British Journal of Clinical Pharmacology, Volume 92, Issue 1, Page 220-229, January 2026.
Aims This study investigated factors associated with and outcomes of combined loop diuretics with hydrochlorothiazide (HCTZ) for acute decompensated heart failure (ADHF). Methods In this retrospective study, adults hospitalized for ADHF and who received intravenous loop diuretics between January 2016 and March 2023 were enrolled.
Chia‐Chen Hsu, Hsien‐Chih Chiu, Ju‐Chieh Wung, Yueh‐Ching Chou, Yuh‐Lih Chang, Chian‐Ying Chou, Chin‐Chou Huang   +6 more
wiley   +1 more source

Effects of Mineralocorticoid Receptor Gene Disruption on the Components of the Renin-Angiotensin System in 8-Day-Old Mice [PDF]

, 1999
Christine Hübert, Jean-Marie Gasc, Stefan Berger, Günther Schütz, Pierre Corvol   +4 more
openalex   +1 more source

Fabp5 Is the Key Regulator Mediating γ‐CEHC Differentiation in Osteoblasts and Osteoclasts

BioFactors, Volume 52, Issue 1, January/February 2026.
γ‐CEHC, as a natural Fabp5 inhibitor, ameliorates the osteoporotic microenvironment through a triple‐action mechanism—targeting Fabp5 inhibition → modulating macrophage polarization → balancing bone metabolism—highlighting its translational medical value.
Cheng Cheng, Rong Chen, Minjuan Li, Shuai Lu, Xinping Li, Gengli Cui, Hailing Chen, Xieyuan Jiang   +7 more
wiley   +1 more source

The Effect of Glucocorticoid and Mineralocorticoid Receptor Antagonists in the Skin of Aged Female Mice. [PDF]

Int J Mol Sci
Ali A, Fossas De Mello N, Luo Y, Bensreti H, Melynk S, Shaver JC, Choudhary V, McGee-Lawrence ME, Bollag WB.   +8 more
europepmc   +1 more source

Overexpression of mineralocorticoid receptors does not affect memory and anxiety-like behavior in female mice [PDF]

, 2015
Sofia Kanatsou, Laura E. Kuil, Marit Arp, Melly S. Oitzl, Anjanette Harris, Jonathan R. Seckl, Harm J. Krugers, Marian Joëls   +7 more
openalex   +1 more source

Finerenone: a mineralocorticoid receptor antagonist for the treatment of chronic kidney disease associated with type 2 diabetes

, 2022
Edgar V. Lerma, Daniel J. Wilson
openalex   +1 more source

Genetic Insights and Lifelong Management of Aldosterone Synthase Deficiency: A Case of Hyperreninemic Hypoaldosteronism

Clinical Case Reports, Volume 14, Issue 1, January 2026.
ABSTRACT Aldosterone synthase deficiency is a rare cause of neonatal salt‐wasting and failure to thrive. Routine newborn electrolyte screening after 5 days of life is vital for early detection and prevention of life‐threatening crises. Genetic confirmation enables targeted fludrocortisone therapy, ensuring favorable growth and developmental outcomes.
Mian Muhammad Hassan Ahmed, Rehmana Waris, Samra Batool, Rahmat Gul Omarzai, Abdur Rehman   +4 more
wiley   +1 more source

Nonsteroidal mineralocorticoid receptor antagonists and cardiovascular events in type 2 diabetes: a retrospective study. [PDF]

Eur Heart J Cardiovasc Pharmacother
Chen YH, Fang YW, Chen MT, Liou HH, Tsai MH.   +4 more
europepmc   +1 more source

Mineralocorticoid Receptor Antagonists for Hypertension Management in Advanced Chronic Kidney Disease [PDF]

, 2020
George L. Bakris, Y Fred F YANG, Bertram Pitt   +2 more
openalex   +1 more source